India Active Pharmaceutical Ingredients Market, By Method of Synthesis (Synthetic v/s Biological), By Source (Contact Manufacturing Organizations v/s In-house Manufacturing), By Therapeutic Application (Cardiovascular Diseases, Anti-diabetic Drugs, Oncology Drugs, Neurological Disorders, Musculoskeletal Disorders, Others), By Drug Type (Generics v/s Innovator), By Region, Competition Forecast & Opportunities, FY2027
India active pharmaceutical Ingredients market stood at USD11806.93 million in FY2021 and is expected to grow at a CAGR of 12.24% during the forecast period. This growth can be attributed to high growth of the biopharmaceutical sector in the country. Additionally, increasing geriatric population in India is further expected to boost the demand through FY2027. Furthermore, growing prevalence of chronic diseases such as cardiovascular diseases, diabetes, cancer, respiratory disorders, among others is going to boost the market. According to the World Health Organization (WHO), cardiovascular diseases are the leading cause of death globally, accounting for an estimated 17.9 million lives each year. The major drivers boosting the growth of the India active pharmaceutical ingredients market are the rising drug research and increase in development and manufacturing of drugs and the increasing uptake of biopharmaceuticals. Besides, the sudden outbreak and spread of COVID-19 pandemic across the globe, with India being severely hit by the pandemic crisis, also opened opportunities for the growth of India active pharmaceutical ingredients market. Due to the pandemic spread major countries boycotted China for trade as it was where the virus originated, similarly India also banned all kinds of imports and exports with China. This led to development of manufacturing facilities in the country and improved the status of domestic players. Also, India being a major pharmaceutical hub witnessed demand from various countries across the globe for getting the medical supplies and drugs. This in turn positively influenced the growth of active pharmaceutical ingredients market in the country. Also, supportive government policies such as Atmanirbhar Bharat, Pharma Vision 2020, Production Linked Incentive Scheme, among others is further expected to create lucrative opportunities for the growth of overall pharmaceutical industry and India active pharmaceutical ingredients market. The India active pharmaceutical ingredients market is segmented based on method of synthesis, source, therapeutic application, drug type, company, and region.Based on method of synthesis, the market is further segmented into synthetic and biological.
The synthetic method of synthesis dominated the market with a share of 56.29% in FY2021 on account of the easy availability of raw materials and easier process for development of active pharmaceutical ingredients. While the biological method of synthesis segment is expected to grow at a rate of 13.21% during the forecast period owing to the growing demand for vaccines, monoclonal antibodies, recombinant proteins, biosimilars, among others. Based on drug type, the market is further segmented into generics and innovators. Generics dominated the market with a share of 69.56% in FY2021 as the country also has a large pool of scientists and engineers with a potential to steer the industry ahead to greater heights. India ranks 3rd in terms of pharmaceutical production by volume and 14th by value. The Indian pharmaceutical industry accounts for 2nd largest number of Abbreviated New Drug Application. Teva API India Limited, Pfizer Ltd., Ipca Laboratories Limited, Dr. Reddy’s Laboratories Ltd., Sun Pharmaceutical Industries Limited, Cipla Limited, Lupin Limited, Aurobindo Pharma Limited, Aarti Drugs Ltd., IOL Chemicals and Pharmaceuticals Limited, Divis Laboratories Ltd., Granules India Limited, Laurus Labs Ltd., Solara Active Pharma Sciences, GlaxoSmithKline Pharmaceuticals Ltd, are some of the major companies operating in the India active pharmaceutical ingredients market. Major companies are developing advanced technologies, receiving approvals from regulatory bodies, and launching new products to stay competitive in the market. Other inorganic growth strategies include mergers & acquisitions, research collaborations, joint ventures, and new product developments to sustain themselves amidst fierce competition.
• To analyze historical growth in the market size of India active pharmaceutical ingredients market from FY2017 to FY2021. • To estimate and forecast the market size of India active pharmaceutical ingredients market from FY2022 to FY2027 and growth rate until FY2027. • To classify and forecast India active pharmaceutical ingredients market based on method of synthesis, source, therapeutic application, drug type, company, and regional distribution. • To identify dominant region or segment in the India active pharmaceutical ingredients market. • To identify drivers and challenges for India active pharmaceutical ingredients market. • To examine competitive developments such as expansions, new product launches, mergers & acquisitions, etc., in India active pharmaceutical ingredients market. • To identify and analyze the profiles of leading players operating in India active pharmaceutical ingredients market. • To identify key sustainable strategies adopted by market players in India active pharmaceutical ingredients market. The analyst performed both primary as well as exhaustive secondary research for this study.Initially, the analyst sourced a list of manufacturers across the country.
Subsequently, the analyst conducted primary research surveys with the identified companies.While interviewing, the respondents were also enquired about their competitors.
Through this technique, the analyst could include the manufacturers which could not be identified due to the limitations of secondary research. The analyst examined the manufacturers, distribution channels and presence of all major players across the country. The analyst calculated the market size of India active pharmaceutical ingredients market using a bottom-up approach, wherein data for various end-user segments was recorded and forecast for the future years. The analyst sourced these values from the industry experts and company representatives and externally validated them through analyzing historical data of these segments for getting an appropriate, overall market size.
Various secondary sources such as company websites, news articles, press releases, company annual reports, investor presentations and financial reports were also studied by the analyst.
Key Target Audience:
• Active Pharmaceutical Ingredients manufacturers/ suppliers/ distributors • Market research and consulting firms • Government bodies such as regulating authorities and policy makers • Organizations, forums and alliances related to Active Pharmaceutical Ingredients The study is useful in providing answers to several critical questions that are important for the industry stakeholders such as manufacturers, suppliers and partners, end users, etc., besides allowing them in strategizing investments and capitalizing on market opportunities.
In this report, India Active Pharmaceutical Ingredients market has been segmented into following categories, in addition to the industry trends which have also been detailed below: • India Active Pharmaceutical Ingredients Market, By Method of Synthesis: o Synthetic o Biological • India Active Pharmaceutical Ingredients Market, By Source: o Contract Manufacturing Organizations o In-house • India Active Pharmaceutical Ingredients Market, By Therapeutic Application: o Cardiovascular Diseases o Anti-diabetic Drugs o Oncology Drugs o Neurological Disorders o Musculoskeletal Disorders o Others • India Active Pharmaceutical Ingredients Market, By Drug Type: o Generics o Innovator • India Active Pharmaceutical Ingredients Market, By Region: o West o South o North o East
Company Profiles: Detailed analysis of the major companies present in India Active Pharmaceutical Ingredients market.
With the given market data, we offers customizations according to a company’s specific needs. The following customization options are available for the report:
• Detailed analysis and profiling of additional market players (up to five).
Our reports have been used by over 10K customers, including:
The healthcare analytical testing services market is projected to reach USD 9.8 billion by 2026 from USD 5.6 billion in 2021, at a CAGR of 11.9%. Growth in the market is driven by the rising trend of outsourcing of analytical testing by pharmaceutical companies and medical device companies, an increasing number of clinical trials, and the...
175 pages •
By The Business Research Company
• Sep 2021
Major players in the pharmaceutical active pharmaceutical ingredients (API) manufacturing market are Teva Pharmaceutical Industries Ltd., Sun Pharmaceutical Industries Ltd., Boehringer Ingelheim), Pfizer, Inc. and Aurobindo Pharma. The global pharmaceutical API manufacturing market is expected to grow from $170.06 billion in 2020 to...
175 pages •
By The Business Research Company
• Sep 2021
Major players in the pharma microbiology testing kits market are F. Hoffmann-La Roche AG, Becton, Dickinson and Company, Abbott Laboratories, ThermoFisher Scientific and Lucideon. The global pharma microbiology testing kits market is expected to grow from $4.57 billion in 2020 to $4.99 billion in 2021 at a compound annual growth rate...
175 pages •
By The Business Research Company
• Sep 2021
Major players in the pyrogen testing market are Thermo Fisher Scientific, Inc., Merck KGaA, Charles River Laboratories, Inc., Lonza Group, Ellab A/S, Nelson Laboratories Inc., Associates of Cape Cod, Inc., GenScript, BioMerieux, Hyglos GmbH, Sanquin, Wako Chemicals USA, Inc., and Pyrostar. The global pyrogen testing market is expected...
Active Pharmaceutical Ingredients (API) market is one of the high-growth prospect industries with potential opportunities throughout 2028. The Active Pharmaceutical Ingredients (API) Market growth analysis and insights report analyzes emerging market trends, market size outlook, potential opportunities, market share by Active Pharmaceutical...
Pharmaceutical Intermediates market is one of the high-growth prospect industries with potential opportunities throughout 2028. The Pharmaceutical Intermediates Market growth analysis and insights report analyzes emerging market trends, market size outlook, potential opportunities, market share by Pharmaceutical Intermediates types, applications....
The global orphan drugs market reached a value of US$ 174.7 Billion in 2020. Looking forward, the analyst expects the market to grow at a CAGR of 9.8% during 2021-2026. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic. These insights are...
Placenta Growth Factor (Vascular Endothelial Growth Factor Related Protein or PGF) - Drugs In Development, 2021 Summary Placenta Growth Factor (Vascular Endothelial Growth Factor Related Protein or PGF) - Placental growth factor is a protein encoded by the PGF gene. Placental growth factor (PGF)...
Coagulation Factor XI (Plasma Thromboplastin Antecedent or F11 or EC 18.104.22.168) - Drugs In Development, 2021 Summary According to the recently published report ’Coagulation Factor XI - Drugs In Development, 2021’; Coagulation Factor XI (Plasma Thromboplastin Antecedent or F11 or EC 22.214.171.124) pipeline...
230 pages •
By Asia Market Information & Development Company
• Aug 2021
China’s demand for Heparin has grown at a fast pace in the past decade. In the next decade, both production and demand will continue to grow. The Chinese economy maintains a high speed growth which has been stimulated by the consecutive increases of industrial output, imports & exports, consumer consumption...
You can change your Cookie Settings at any time but parts of our site will not function correctly without them.